Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Beta cell glutamate receptor antagonists: novel oral antidiabetic drugs?

Type 2 diabetes occurs when the pancreatic beta cells fail to meet the increased insulin requirement in insulin-resistant individuals. A new therapeutic approach targeting glutamate receptors on beta cells improves insulin secretion and preserves beta cell mass.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: Dextrorphan actions and the regulation of insulin secretion.

Kim Caesar/Nature Publishing Group

References

  1. Halban, P.A. et al. Diabetes Care 37, 1751–1758 (2014).

    Article  Google Scholar 

  2. Marquard, J. et al. Nat. Med. 21, 363–372 (2015).

    CAS  Article  Google Scholar 

  3. Maechler, P. & Wollheim, C.B. Nature 402, 685–689 (1999).

    CAS  Article  Google Scholar 

  4. Feldmann, N. et al. Mol. Cell. Endocrinol. 338, 46–57 (2011).

    CAS  Article  Google Scholar 

  5. Vetterli, L. et al. Mol. Biol. Cell 23, 3851–3862 (2012).

    CAS  Article  Google Scholar 

  6. Gheni, G., et al.. Cell Rep. 9, 661–673 (2014).

    CAS  Article  Google Scholar 

  7. Inagaki, N. et al. FASEB J. 9, 686–691 (1995).

    CAS  Article  Google Scholar 

  8. Cabrera, O. et al. Cell Metab. 7, 545–554 (2008).

    CAS  Article  Google Scholar 

  9. Hardingham, G.E. & Bading, H. Nat. Rev. Neurosci. 11, 682–696 (2010).

    CAS  Article  Google Scholar 

  10. Dadi, P.K. et al. J. Biol. Chem. 289, 12435–12445 (2014).

    CAS  Article  Google Scholar 

  11. Soleimanpour, S.A. et al. J. Biol. Chem. 285, 40050–40059 (2010).

    CAS  Article  Google Scholar 

  12. Colella, M. et al. Proc. Natl. Acad. Sci. USA 105, 2859–2864 (2008).

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Claes B Wollheim or Pierre Maechler.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wollheim, C., Maechler, P. Beta cell glutamate receptor antagonists: novel oral antidiabetic drugs?. Nat Med 21, 310–311 (2015). https://doi.org/10.1038/nm.3835

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.3835

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing